ТОМ 6, СТ. 170 (стр. 648-661) // Сентябрь 2005г.
Дельтаран - новый нейропептид в лечении пограничных психических нарушений у детей
Козловская Г.В., Калинина М.А., Голубева Н.И.
ГУ НЦПЗ РАМН, Москва
( статья в формате PDF. Для просмотра необходим Adobe Acrobat Reader )
DELTARAN - NEW NEYROPEPTID in TREATMENT of the BORDER PSYCHIC BREACHES Beside Children
Kozlovskaya G.V., Kalina M.A., Golubeva N.I.
RUSSIAN ACADEMY of MEDICAL SCIENCE MENTAL HEALTH RESEARCH CENTRE, Moscow
The comparative open clinical study preparation "Deltaran" was Organized and "Glicin" in treatment of easy cognitive dysfunction, syndrome of hyperactivity with deficit of attention, mixed disorders of behavior and emotion, anxiety and phobic disorders beside babies and children 3-10 years. The Condition of patients was valued by psychopathologic methods and psychometric scales PANSS, CGI, adapted to baby age. The Treatment was conducted course on 10 days at month, for 2 months cjntract. The Results were followed for 2 months after treatment. The statistical methods of the processing result were used.
The noted reduction of physchic disturbance of beside majority patient and improvement of the phychic condition, especially improvement to functions of attention, memories, congnitive activity, volitional function, normalization of autonomic function. The statistical significant differences were revealed between effect "Deltaran" and "Glinic" (p<0,001). The Complications on treatment "Deltaran" was not noted.